(WBA) Walgreens Boots Alliance - Ratings and Ratios

Walgreens Boots Alliance (WBA) is a global leader in healthcare, pharmacy, and retail, operating across the U.S., Germany, the U.K., and other international markets. The company is structured into three core segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. Each segment plays a critical role in WBAs diversified business model, which spans traditional retail pharmacy services, health and wellness offerings, and value-based care solutions.

The U.S. Retail Pharmacy segment is the backbone of WBAs domestic operations, encompassing over 13,000 retail drugstores across the U.S. These locations provide a wide range of services, including health and wellness programs, specialty pharmacy services, and home delivery options. The segment also generates significant revenue from the sale of beauty, personal care, and general merchandise products, making it a key contributor to WBAs overall profitability.

Internationally, WBA operates a robust network of pharmacy-led health and beauty retail businesses under the Boots brand in the U.K., Ireland, and Thailand. Additionally, the company has a strong presence in Latin America through its Benavides and Ahumada brands in Mexico and Chile, respectively. This segment focuses on prescription drugs, health and wellness products, and consumer goods, catering to diverse markets with varying regulatory and consumer demands.

The U.S. Healthcare segment represents WBAs strategic push into value-based care and integrated healthcare services. This includes VillageMD, a rapidly growing provider of primary, specialty, and urgent care services delivered through traditional clinics, in-home visits, and telehealth platforms. Shields, a specialty pharmacy integrator, and CareCentrix, a leader in post-acute and home care management, further strengthen WBAs position in the healthcare ecosystem. These investments highlight WBAs commitment to transitioning from a traditional retail pharmacy model to a more comprehensive healthcare provider.

From a financial perspective, WBAs market cap of $9.9 billion reflects its scale and stability. The forward P/E of 7.69 indicates investor confidence in the companys ability to deliver growth, particularly as it expands its healthcare offerings. However, the current P/E of 0.00 suggests that WBA